Targeting Hypoxia-Inducible Factor-1α in Pancreatic Cancer: siRNA Delivery Using Hyaluronic Acid-Displaying Nanoparticles
<b>Background/Objectives:</b> Conventional anticancer therapies often lack specificity, targeting both cancerous and normal cells, which reduces efficacy and leads to undesired off-target effects. An additional challenge is the presence of hypoxic regions in tumors, where the Hypoxia Ind...
Saved in:
Main Authors: | Alice Spadea (Author), Annalisa Tirella (Author), Julio Manuel Rios de la Rosa (Author), Enrique Lallana (Author), Manal Mehibel (Author), Brian Telfer (Author), Nicola Tirelli (Author), Margaret Jayne Lawrence (Author), Kaye J. Williams (Author), Ian J. Stratford (Author), Marianne Ashford (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuroprotective Effect of siRNA Entrapped in Hyaluronic Acid-Coated Lipoplexes by Intravitreal Administration
by: Marcela Coelho Silva Ribeiro, et al.
Published: (2021) -
Hypoxia-Responsive Azobenzene-Linked Hyaluronate Dot Particles for Photodynamic Tumor Therapy
by: Sohyeon Lee, et al.
Published: (2022) -
Hyaluronic acid-modified redox-sensitive hybrid nanocomplex loading with siRNA for non-small-cell lung carcinoma therapy
by: Daoyuan Chen, et al.
Published: (2022) -
siRNA-induced silencing of hypoxia-inducible factor 3α (HIF3α) increases endurance capacity in rats
by: S Drozdovska, et al.
Published: (2016) -
Targeting the hypoxia pathway to treat pancreatic cancer
by: Erickson LA, et al.
Published: (2015)